Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Implantable Biodegradable Scaffold Helps Broken Bones Regrow Quickly

By HospiMedica International staff writers
Posted on 29 Aug 2025

For most broken bones, natural healing occurs while the patient wears a cast or brace. More...

However, severe or complex fractures often require surgical intervention with grafts, scaffolds, or metal fixation devices to ensure proper alignment and regrowth. These cases highlight the need for better solutions that not only stabilize bone but also actively accelerate healing. Now, researchers have developed a new biodegradable implant to meet this challenge.

Researchers at Penn State (University Park, PA, USA) created CitraBoneQMg, an implantable scaffold that combines magnesium and glutamine with citric acid to stimulate bone regrowth. Unlike traditional citric acid–based implants, this new scaffold harnesses natural molecules found in the body and food to enhance intracellular energy metabolism. The materials work synergistically to regulate key energy pathways, AMPK and mTORC1, providing stem cells with the power to grow and differentiate into bone.

To evaluate the device, the team implanted CitraBoneQMg into cranial defects in rats and compared bone healing to that achieved with citric acid–only scaffolds and traditional bone materials. The study, published in Science Advances, demonstrated that the new scaffold supported bone growth with superior results while maintaining safety and biocompatibility.

After 12 weeks, bone growth around the injury increased by 56% compared to citric acid–only scaffolds and by 185% compared to traditional bone materials. In addition to bone regeneration, researchers observed nerve repair and anti-inflammatory effects at the implant site. The scaffold also showed inherent photoluminescent and photoacoustic properties, making it easy to track in vivo using imaging techniques.

The findings suggest that releasing nutrients directly at the site of injury via the scaffold enables higher concentrations to reach bone cells compared to oral supplements. The implant may therefore offer a streamlined way to promote long-term healing while providing imaging advantages for monitoring patient recovery. Researchers plan to continue refining the technology and exploring its applications in broader orthopedic care.

“The three molecules work as a healing recipe for the bone, paving the way for a new way of thinking of bone repair,” said Su Yan, Assistant Research Professor of Biomedical Engineering at Penn State and co-corresponding author of the study. “Alongside rapid bone growth, we also saw nerve regeneration and anti-inflammation properties at the site of the scaffold, two elements that are important to long-term healing of the bone.”

Related Links:
Penn State


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.